Home Newsfeeds Oppenheimer Downgrades Edwards Lifesciences to Perform

Oppenheimer Downgrades Edwards Lifesciences to Perform

Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.

byBenzinga Newsdesk

October 28, 2022

1 minute read

Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.

Alibaba, Nio Fall Over 2%: Hang Seng Weakens After Fed Sees Rate Hikes Through Next Year

By Bhavik Nair

December 14, 10:18 PM

Hong Kong stocks witnessed a sell-off on Thursday despite the Federal Reserve’s 50 basis points rate hike being on anticipated lines as central bank officials projected rate increases through next year

BABA

Asia Closes in Red, Europe Trades Lower Along with Commodities – Global Markets Today While US Was Sleeping

By Akanksha Bakshi

September 5, 6:56 AM

On Friday, September 1, the U.S. markets ended mixed after the latest jobs report data release. In August, the U.S. economy added 187,000 jobs, slightly beating the revised July figure of 157,000 and exceeding the expected 170,000. However, unemployment rose from 3.5% in July to 3.8% in August.

ADIV